Anove LogoAnove LogoExplAIn
MapsAI frontrunners
Back to Directory

M&M (Minority & Majority classifier)

by Prinses Máxima Centrum

AI Application
Low Confidence

M&M (Minority & Majority classifier) is a machine-learning tool that suggests the tumour type and subtype of a childhood cancer from RNA-sequencing data of the tumour. It is used in a paediatric oncology diagnostic laboratory, where pathologists and haematologists make the diagnosis. Its developers at the Prinses Máxima Centrum say it compares each new patient's gene-expression profile with all profiles measured before, combining two ensembles of weighted random-forest models, one aimed at rare and one at more frequent tumour (sub)types. It covers 52 tumour types and 96 subtypes; the developers report about 99% precision for confident tumour-type calls on internal test data; calls below a probability threshold are flagged as low confidence. The Máxima describes it as a tool the pathologist or haematologist uses to confirm their own diagnosis or, when in doubt, to reach a precise one; the paper says its output should always be weighed against other information. The R package is on GitHub under GPL-3.0 and the trained models on Zenodo; hosting is not stated.

Visit Website

Transparency Score

Weighted across four pillars · updated October 20, 2026

Overall grade
10% weighted
ABCDF
Model
—
Not yet assessed
Infrastructure
—
Not yet assessed

Capabilities

Paediatric Tumour Type Classification
Tumour Subtype Classification
Rna Expression Profile Comparison
Diagnosis Confirmation Support
Confidence Scoring

Vendor Information

Complete information about the vendor/provider of this AI application

Prinses Máxima CentrumView all products →
Prinses Máxima Centrum voor Kinderoncologie B.V.(Trading as: Prinses Máxima Centrum)
Contact Information
www.prinsesmaximacentrum.nl
Registered Address
Heidelberglaan 25, Utrecht, Utrecht, 3584 CS, NL

EU AI Act Provider Information

Verification Status:
Unverified
Prinses Máxima Centrum voor Kinderoncologie B.V.(Trading as: Prinses Máxima Centrum)
Heidelberglaan 25, Utrecht, Utrecht, 3584 CS, NL
For M&M, the Máxima's developers state in their paper that 'M&M's classification should always be assessed in light of other available information to come to a final diagnosis', that 'additional verification showing the prospective performance in an extended clinical setting is needed for standard-of-care use', that subtype calls perform worse than tumour-type calls, that (very) rare tumour (sub)types with fewer than three reference samples are excluded, and that replacing the DKFZ CNS methylation classifier with M&M 'would currently not be recommended'. Calls below a probability threshold (about 0.82 for tumour type, 0.72 for subtype) are reported as low confidence. The GitHub README says input transcript names must be HGNC symbols (Wallis et al., eBioMedicine 2025, https://europepmc.org/article/PMC/PMC11784659; https://github.com/princessmaximacenter/MnM; both read 2026-10-20).
Compliance & Risk

Get insights into risk by running assessments on this AI application.

Work at Prinses Máxima Centrum? Claim this listing to correct or complete the data.

Added: October 20, 2026
Updated: October 20, 2026

Ready to manage AI applications?

Track, assess, and govern your AI applications with Anove.

Anove LogoAnove LogoAnove International B.V.

Helping organizations discover and manage AI applications responsibly. Your trusted source for AI governance and compliance.

Quick Links

  • Browse Directory
  • FAQ
  • AI maps by industry
  • Sign In

Resources

  • Documentation
  • Status
  • Anove.ai

Terms

  • Privacy Policy
  • Terms & Conditions
  • Responsible Disclosure
  • AI Legal Notice
  • Security Policy

© 2026 Anove International B.V. All rights reserved.